Society for Translational Oncology

The Society for Translational Oncology (STO) is a professional association committed to speeding the discovery and translation of important new treatments in the field of cancer medicine to the practice of global oncology by:

* Bringing knowledge and strategies for critical new developments in cancer treatment into the practice environment of the community oncologist;
* Bridging the “translational gap” between discovery and delivery of care to the patient;
* Providing educational activities to improve physician competencies and strategies for screening, prevention, diagnosis, treatment, and -management of patients with cancer.

The Society for Translational Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

STO's official journal is The Oncologist, a premier peer-reviewed oncology journal.

STO is tax-exempt as a 501(c)(3) foundation (EIN: 20-3186261).

For more information, send email to admin@sto-online.org